Edgewell Personal Care
Spun off from Energizer to run shaving, sun-care, and grooming brands independently.
Something off on this page? Send us feedback.
Profile
Sells shaving razors and blades under Schick and Wilkinson Sword, sun and skin-care lines spanning Banana Boat, Hawaiian Tropic, Jack Black, and Cremo, and body care under the digitally native Billie brand. Growth comes mainly through acquired brands, with a lasting second position in shaving behind Procter & Gamble's Gillette.
Separated from Energizer Holdings' battery business in 2015 to operate as an independent personal-care company built from decades of acquired grooming and sun-care brands.
Schick and Wilkinson Sword anchor a Wet Shave franchise holding a lasting second position behind Procter & Gamble's Gillette. Sun and skin care spans mass-market Banana Boat and Hawaiian Tropic alongside premium grooming brands Jack Black and Cremo, plus the digitally native Billie brand.
Growth has come mostly through acquisitions rather than new product development, paired with periodic pruning — most recently an agreement to exit the Feminine Care lines and concentrate on shaving and sun and skin care. Most of the workforce is based outside the US.
Recurring restructuring charges tied to manufacturing consolidation and sun-care reformulation following a sunscreen safety recall have shaped recent results.
Company facts
Categories
Key statistics
Year to date +72.4% · Average volume (30d) 586.5K
Analysts
Unavailable right now.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q3 FY26 | $0.65 | $0.72 | +11.6% | $574.9M | $570.1M | −0.8% | +2.35% |
| May 6, 2026Q2 FY26 | $0.43 | $0.60 | +39.5% | $518.5M | $519.5M | +0.2% | −3.31% |
| Feb 9, 2026Q1 FY26 | −$0.18 | −$0.16 | +11.1% | $478.2M | $486.8M | +1.8% | +3.59% |
| Nov 13, 2025Q4 FY25 | $0.82 | $0.68 | −17.1% | $485.3M | $537.2M | +10.7% | −1.41% |
Financial highlights
| 12 quarters | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $580.7M | $627.2M | $537.2M | $422.8M | $519.5M | $570.1M | |
| Gross profit | $256.2M | $268.5M | $208.6M | $161.0M | $225.6M | $242.5M | |
| Operating income | $58.9M | $53.7M | −$36.3M | −$800.0K | $46.1M | $25.0M | |
| Net income | $29.0M | $29.1M | −$30.6M | −$65.7M | −$10.6M | $13.7M | |
| Diluted EPS | $0.60 | $0.61 | −$0.66 | −$1.41 | −$0.23 | $0.29 | |
| Gross margin | 44.1% | 42.8% | 38.8% | 38.1% | 43.4% | 42.5% | |
| Operating margin | 10.1% | 8.6% | -6.8% | -0.2% | 8.9% | 4.4% |
Fiscal years (4-quarter sums)FY21 $2.09B · FY22 $2.17B · FY23 $2.25B · FY24 $2.25B · FY25 $2.22B
Revenue by product · Q3 FY26
Revenue by geography · Q3 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $397.1M · Total debt $1.28B · Total assets $3.54B · Shareholders' equity $1.46B
Dividends
Raised for 5 straight years. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 10, 2026 | Jun 10 | Jul 9 | $0.15 | |
| Mar 6, 2026 | Mar 6 | Apr 8 | $0.15 | |
| Dec 4, 2025 | Dec 4 | Jan 8 | $0.15 | |
| Sep 4, 2025 | Sep 4 | Oct 8 | $0.15 | |
| Jun 6, 2025 | Jun 6 | Jul 9 | $0.15 | |
| Mar 5, 2025 | Mar 5 | Apr 9 | $0.15 | |
| Dec 3, 2024 | Dec 3 | Jan 8 | $0.15 | |
| Sep 4, 2024 | Sep 4 | Oct 3 | $0.15 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 46.08M · Float 41.32M · 89.7% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.35M | 15.96% | 13F | Aug 7, 2026 |
| Brandes Investment Partners, LP | 7.06M | 15.32% | 13F | Aug 14, 2026 |
| American Century Companies Inc | 5.41M | 11.73% | 13F | Aug 12, 2026 |
| Stowers Institute for Medical Research | 5.06M | 11.00% | 13G | Jun 5, 2026 |
| Rubric Capital Management LP | 3.54M | 7.69% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Nov 20, 2025 | John M. Dunham | officer: Chief Accounting Officer | −333 | $17.21 |
Peers
- Procter & Gamble
Global #1 in wet shave via Gillette, the category-defining rival
- Kenvue
Mass sun-care rival via Neutrogena; pending Kimberly-Clark acquisition
- Unilever (ADR)
Men's grooming rival via Dove Men+Care/Axe; razor-subscription tie now indirect
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Edgewell Personal Care | $29.05 | −0.03% | $1.34B | — | 12.4 | 0.7 | −9.1% |
| Procter & Gamble | $143.75 | +0.01% | $341.75B | 21.7 | 20.5 | 3.9 | +1.5% |
| Kenvue | $19.17 | +0.03% | $36.81B | 22.0 | 16.0 | 2.4 | +3.0% |
| Unilever (ADR) | $63.77 | −2.01% | $140.18B | 21.7 | — | 2.6 | −17.9% |
| Median | 21.7 | 18.3 | 2.6 | +1.5% |